Eraxis Injection 100 mg/vial contains Anidulafungin, a potent antifungal medication used to treat serious fungal infections. It belongs to a class of antifungal drugs known as echinocandins. This medication is primarily used for the treatment of invasive candidiasis, candidemia (Candida infection in the bloodstream), and esophageal candidiasis. Eraxis works by inhibiting the synthesis of an essential component of the fungal cell wall, thereby leading to the destruction of the fungal cells.
Fungal infections can be life-threatening, especially in hospitalized or immunocompromised patients. Individuals undergoing chemotherapy, organ transplantation, or those with weakened immune systems are more vulnerable to invasive fungal infections. Eraxis Injection provides an effective treatment option by specifically targeting fungal cell wall synthesis, which is not present in human cells, making it both effective and selective in its action.
Anidulafungin works by inhibiting the enzyme 1,3-beta-D-glucan synthase. This enzyme is responsible for the formation of beta-D-glucan, an important structural component of the fungal cell wall. When the synthesis of beta-D-glucan is blocked, the fungal cell wall becomes weak and unstable, causing the fungal cells to rupture and die. This mechanism helps eliminate the infection and prevents further spread of the fungus in the body.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Effective treatment for serious systemic fungal infections
Works by inhibiting fungal cell wall synthesis
Highly effective against Candida species
Suitable for hospitalized patients with invasive candidiasis
Administered intravenously for rapid therapeutic effect
Eraxis Injection 100 mg/vial is indicated for the treatment of the following fungal infections:
Candidemia (Candida infection in the bloodstream)
Invasive candidiasis
Esophageal candidiasis
Other serious Candida infections in adults
It is commonly used in patients who are critically ill or immunocompromised and require intravenous antifungal therapy.
Eraxis Injection is administered intravenously by a qualified healthcare professional in a hospital or clinical setting. The treatment usually begins with a loading dose followed by a daily maintenance dose as prescribed by the physician.
The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient’s overall health condition and response to therapy. The medication must be prepared and diluted according to medical guidelines before infusion.
Like other medications, Eraxis Injection may cause certain side effects, although not everyone experiences them.
Common side effects may include:
Fever
Nausea or vomiting
Diarrhea
Headache
Infusion site reactions
Elevated liver enzymes
In rare cases, serious allergic reactions or liver-related complications may occur. Patients should be monitored closely during treatment, especially during intravenous administration.
Eraxis should be used with caution in patients with liver disease or those who have experienced hypersensitivity reactions to echinocandin antifungal drugs. Liver function tests may be required during treatment to monitor for potential liver-related side effects.
Patients should inform their healthcare provider about all medications they are taking, including prescription drugs, over-the-counter medicines, and herbal supplements, to avoid potential interactions.
The safety of Anidulafungin during pregnancy has not been fully established, so it should only be used if clearly needed and prescribed by a healthcare professional. Breastfeeding mothers should consult their doctor before using this medication.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Store Eraxis Injection at the recommended temperature as indicated on the packaging. Keep the vial protected from light and moisture. Ensure the medication is kept out of reach of children and only handled by trained healthcare professionals.
Login Or Registerto submit your questions to seller
No none asked to seller yet